Gene · 8880
Papers1,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic value of FUBP1 in Colorectal cancer and association with immune microenvironment characteristics. | Cancer Treat Res Commun | 2026 | 42641461 | PubTator, text mining | PubMed |
| FUBL-3/FUBP1 mediates mitochondrial stress-induced chromatin remodeling and longevity. | Sci Adv | 2026 | 42341138 | PubTator, text mining | PubMed |
| The RNA-binding protein RBFOX2 suppresses colorectal cancer proliferation and metastasis by reducing FUBP1 mRNA stability to induce mitochondrial dysfunction and ferroptosis. | Discov Oncol | 2026 | 42223720 | PubTator, text mining | PubMed |
| JARID1B-Mediated H3K4me3 Demethylation Promotes Cisplatin Resistance in Oral Squamous Cell Carcinoma Cells via the miR-495-3p/FUBP1 Axis. | Appl Biochem Biotechnol | 2026 | 42166100 | PubTator, text mining | PubMed |
| Stress granule dynamics orchestrate colitis-to-cancer transition via TOM1-mediated disassembly and driven oncogenesis in response to inflammatory oxidative stress. | Redox Biol | 2026 | 42127552 | PubTator, text mining | PubMed |
| Antiviral activity of novel chemical compound 0411, derived from FUBP1-IN-1 against hepatitis B virus by upregulation of DUSP5. | Biochem Pharmacol | 2026 | 42000079 | PubTator, text mining | PubMed |
| Proteome-based investigation of O-GlcNAcylation in a C. elegans model of ageing and Alzheimer's disease: Functional support for earlier hypothesis-generating findings. | PLoS One | 2026 | 41911326 | PubTator, text mining | PubMed |
| Recent Advances in Targeted Therapies for Adult Gliomas. | Curr Neurol Neurosci Rep | 2026 | 41874881 | PubTator, text mining | PubMed |
| MEG3 in glioma stem cells promotes glioblastoma angiogenesis through FUBP3-mediated VGF expression. | Clin Exp Med | 2026 | 41866561 | PubTator, text mining | PubMed |
| Hybrid tuned deep learning model for breast cancer diagnosis using genetic data. | Sci Rep | 2026 | 41865006 | PubTator, text mining | PubMed |
| Roles of RNA-binding proteins in macrophage function regulation and immunotherapy. | Front Cell Dev Biol | 2026 | 41808933 | PubTator, text mining | PubMed |
| U2AF2 controls alternative splicing in speckle-proximal regions in an RS domain-dependent manner. | Nucleic Acids Res | 2026 | 41761909 | PubTator, text mining | PubMed |
| Metabolic reprogramming of glioma-associated macrophages identifies detoxification and energetic macrophages as drivers of immunosuppression and therapeutic vulnerability. | Front Immunol | 2026 | 41756290 | PubTator, text mining | PubMed |
| Diagnostic Potential of Circulating miRNAs in Glioma: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2026 | 41751817 | PubTator, text mining | PubMed |
| Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient. | Cell Oncol (Dordr) | 2026 | 41733805 | PubTator, text mining | PubMed |
| Molecular features in gangliogliomas: a systematic review. | Childs Nerv Syst | 2026 | 41721014 | PubTator, text mining | PubMed |
| Comprehensive Genomic Profiling Across Diverse Solid Tumors: A Real-World Experience From India With FoundationOne®CDx Testing. | Cureus | 2026 | 41717185 | PubTator, text mining | PubMed |
| Correction: The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC. | Mol Cancer | 2026 | 41699630 | PubTator, text mining | PubMed |
| Feature extraction in sensor plant disease datasets using reformed membership functions independent of class variables. | Sci Rep | 2026 | 41617750 | PubTator, text mining | PubMed |
| NRF2: Master regulator of cellular homeostasis and therapeutic vulnerability in cancer. | Redox Biol | 2026 | 41616572 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8880/papers